Pneumonia (kids)
[display-posts category=”paediatrics”]
- Epidemiology
- common condition
- 40 per 1,000 in children < 5 years of age
- 15 per 1,000 in children 514 years of age
- males more commonly affected than females
- presents with fever, cough, tachypnoea and possibly grunting
- can present as
- fever without source
- abdominal pain
- meningism
- tachypnoea by itself does not discriminate children with or without pneumonia
- auscultation unreliable
- common condition
- Causes
- viral more common than bacterial
- differentiation best done clinically as XR, WCC, neutrophils, CRP all unreliable for differentiation
- viruses
- responsible for the majority of cases, especially in infants
- RSV responsible for approximately 30% of cases
- influenza
- parainfluenza
- adenovirus
- often causes a neutrophilia
- bacteria
- Strep. pneumoniae (especially in children < 5years of age)
- Staph aureus
- Mycoplasma pneumoniae
- up to 30% of community pneumonias
- mean age 6.3 +/ 3.5 yrs
- associated nonrespiratory symptoms include Kawasaki syndrome, Erythema multiforme, cold urticaria, Guillain Barre
- Chlamydia trachomatis
- Clinical
- fever, cough, tachypnoea
- Diagnose clinically if signs of lower respiratory tract infection – and wheezing syndrome, foreign body have been ruled out
- Only need CXR if suspect severe or complicated
- Red flags
- Respiratory distress
- Apnoeas
- Hypoxaemia/cyanosis
- Marked tachycardia
- Altered mental state
- empyema
- Assessment
- Clinical features
- difficult to differentiate bacterial from viral infection on clinical grounds
- wheeze in preschooler makes bacterial cause unlikely
- bilateral signs make viral more likely
- Mycoplasma has indolent course with variable signs such as crackles, wheeze diffuse or focal
- XR changes of lobar or segmental consolidation makes bacterial more likely
- cavitations and pleural effusions are more likely bacterial esp Staph Aureus
- Investigation
- CXR
- useful with isolated signs
- less helpful with widespread wheeze and/or crackles
- ‘round’ pneumonia associated with Staph aureus infection
- blood culture – in patients with likely bacterial pneumonia needing admission
- nasopharyngeal aspirate for PCR
- can be useful in young children to identify virus, older children for mycoplasma
- not useful for bacterial culture
- WCC, CRP and ESR unhelpful in determining cause
- CXR
- Clinical features
- Management
- most managed at home with early community review
- Antibiotics
- First line – amoxicillin 30mg/kg up to 1g TDS for 3 -5 days
- 2nd line – cefuroxime
- Anaphylaxis – azithromycin 10mg/kg up to 500mg PO for 3 days ( or doxycycline)
- admission indicated if
- age < 6-12 months
- toxic appearance
- significant respiratory distress
- hypoxia
- extensive consolidation, effusion or cavitations on XR
- dehydration
- not tolerating oral antibiotics
- failure to respond to 48 hours of oral antibiotics
- previous cardiorespiratory compromise, congenital heart disease, prematurity, immunodeficiency, trisomy 21
- geographic location, access to travel, other social issues
- more severe pneumonia
- IV flucloxacillin and 3rd generation cephalosporin
- suspected Mycoplasma or Chlamydia pneumonia, or failure to improve with amoxycillin/penicillin monotherapy by 48 hours requires erythromycin or roxithromycin or azithromycin
- Follow up CXR in 4-6 weeks only if complciated/severe
Protracted bacterial bronchitis
- Criteria
- Wet sounding cough
- Present > 4 weeks
- Isolated symptom and child otherwise well
- Wet and moist in nature, with rattly sound sometimes present on chest exam
- Present day and night, worse with changing posture
- Not SOB – aside from coughing fits
- Treatment
- Augmentin for 2 weeks
- If helpful but not fully resolved can extend to 4 weeks